Literature DB >> 2463792

Disulfide and secondary structures of recombinant human granulocyte colony stimulating factor.

H S Lu1, T C Boone, L M Souza, P H Lai.   

Abstract

Molecular characteristics and secondary structures of recombinant methionyl human granulocyte colony stimulating factor produced by genetically engineered Escherichia coli are described. Limited radiolabeling of the protein with tritiated iodoacetate and determination of the labeled residue revealed that this recombinant protein contains only one free cysteine at position 17 which is not essential for activity. The free cysteine is inaccessible to modification unless the molecule is unfolded under denaturing conditions. The molecule forms two disulfide bridges which were assigned as Cys(36)-Cys(42) and Cys(64)-Cys(74) based on the results of isolation and characterization of disulfide-containing peptides obtained from a subtilisin digest of the intact protein. CD analyses and secondary structure prediction suggest that the molecule is abundant in alpha-helical structures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463792     DOI: 10.1016/0003-9861(89)90567-5

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  19 in total

1.  Conformational changes of recombinant human granulocyte-colony stimulating factor induced by pH and guanidine hydrochloride.

Authors:  L O Narhi; W C Kenney; T Arakawa
Journal:  J Protein Chem       Date:  1991-08

2.  Site-Specific Protein PEGylation: Application to Cysteine Analogs of Recombinant Human Granulocyte Colony-Stimulating Factor.

Authors:  Mary S Rosendahl; Daniel H Doherty; Darin J Smith; Alison M Bendele; George N Cox
Journal:  Bioprocess Int       Date:  2005-04

3.  Recombinant granulocyte colony-stimulating factor (rG-CSF): pharmacoeconomic considerations in chemotherapy-induced neutropenia.

Authors:  D Faulds; N J Lewis; R J Milne
Journal:  Pharmacoeconomics       Date:  1992-04       Impact factor: 4.981

4.  Expression of recombinant human mutant granulocyte colony stimulating factor (Nartograstim) in Escherichia coli.

Authors:  F R Gomes; A C Maluenda; J O Tápias; F L S Oliveira; L C Sá-Rocha; E Carvalho; P L Ho
Journal:  World J Microbiol Biotechnol       Date:  2012-05-01       Impact factor: 3.312

5.  Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state.

Authors:  Stephen W Raso; Jeff Abel; Jesse M Barnes; Kevin M Maloney; Gary Pipes; Michael J Treuheit; Jonathan King; David N Brems
Journal:  Protein Sci       Date:  2005-09       Impact factor: 6.725

6.  Determination of Critical Quality Attributes for a Biotherapeutic in the QbD Paradigm: GCSF as a Case Study.

Authors:  Sumit K Singh; Deepak Kumar; Anurag S Rathore
Journal:  AAPS J       Date:  2017-09-05       Impact factor: 4.009

Review 7.  Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions.

Authors:  L M Hollingshead; K L Goa
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

8.  Construction, Purification, and Characterization of a Homodimeric Granulocyte Colony-Stimulating Factor.

Authors:  Gitana Mickiene; Indre Dalgediene; Zilvinas Dapkunas; Gintautas Zvirblis; Henrikas Pesliakas; Algirdas Kaupinis; Mindaugas Valius; Edita Mistiniene; Milda Pleckaityte
Journal:  Mol Biotechnol       Date:  2017-10       Impact factor: 2.695

9.  Characterization of two fluorescent tryptophans in recombinant human granulocyte-colony stimulating factor: comparison of native sequence protein and tryptophan-deficient mutants.

Authors:  C G Kolvenbach; S Elliott; R Sachdev; T Arakawa; L O Narhi
Journal:  J Protein Chem       Date:  1993-04

10.  Sequence and structural relationships in the cytokine family.

Authors:  P Manavalan; D L Swope; R M Withy
Journal:  J Protein Chem       Date:  1992-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.